Navigation Links
Sanofi-aventis and Merrimack Pharmaceuticals Enter Into a Worldwide Collaboration and Licensing Agreement on MM-121, an Anti-ErbB3 Monoclonal Antibody
Date:10/1/2009

apies and chemotherapy in a number of tumor types.

"We believe that MM-121 has the potential to serve as an important new treatment for multiple forms of cancer," said Robert Mulroy, President and Chief Executive Officer of Merrimack. "We are pleased to partner with sanofi-aventis, a premier, global pharmaceutical company with broad oncology expertise. Together, we hope to work with the international research community to accelerate the development of MM-121 for the benefit of patients."

Merrimack developed MM-121 after identifying the importance of ErbB3 through its Network Biology approach, a fully integrated drug discovery and development technique that combines biology, engineering, and computational modeling to better understand the underlying complexity of disease pathways. The information derived from Network Biology informs the strategic decisions guiding early pharmaceutical discovery as well as helping to advance candidates through pre-clinical, clinical development and towards commercialization.

The effectiveness of the license and collaboration is subject to antitrust clearance under the Hart-Scott-Rodino

Antitrust Improvements Act and other customary regulatory approvals.

About Merrimack

Merrimack Pharmaceuticals, Inc. is a biotechnology company focused on the discovery and development of novel treatments for cancer and autoimmune disease. Its first two oncology pipeline candidates, MM-121 and MM-111 are currently in Phase 1 clinical development. The Company's proprietary Network Biology discovery platform, developed with the help of leading scientists from MIT and Harvard, enables the high-throughput profiling of protein networks as a basis for improved validation, lead identification and speed in the development of innovative, effective and well tolerated therapeutics. MM-121 and MM-111 are investigational drugs
'/>"/>

SOURCE Merrimack Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations
2. Insulin Analogues From Novo Nordisk, Eli Lilly and Sanofi-Aventis Will Drive Growth in the Type 1 Diabetes Drug Market
3. Sanofi-aventis Stands Behind the Safety of Lantus(R)
4. Fovea Pharmaceuticals to be Acquired by sanofi-aventis
5. Merrimack Pharmaceuticals Completes Enrollment in a Phase 2 Study of MM-093 in Patients with Rheumatoid Arthritis
6. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
7. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
8. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
9. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
10. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
11. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/14/2014)... , Sept. 14, 2014 /PRNewswire-iReach/ -- "Hematoma Global Clinical ... clinical trial scenario. This report provides elemental information and ... includes an overview of the trial numbers and their ... across the globe. The databook offers a preliminary coverage ... prominence of the sponsors and also provides briefing pertaining ...
(Date:9/14/2014)... , September 14, 2014 Elbit ... EMITF ) announced today further to the Company,s ... (the "Company,s Previous Reports"), that it was informed by ... US$ 12.5 million by  Shanghai GEOC Hengtong Investment Limited ... the framework of the present investment round in InSightec, ...
(Date:9/12/2014)... 2014 In the current outcomes-focused market, ... Health Outcomes Liaison (HOL) staff to serve as ... and other important healthcare decision makers. As the ... successful companies will need to understand how to ... To help organizations identify industry trends ...
Breaking Medicine Technology:Hematoma Therapeutics Clinical Trials Market Overview on Companies, Top Institutes & Clinical Profiles to 2014 2Hematoma Therapeutics Clinical Trials Market Overview on Companies, Top Institutes & Clinical Profiles to 2014 3Hematoma Therapeutics Clinical Trials Market Overview on Companies, Top Institutes & Clinical Profiles to 2014 4Hematoma Therapeutics Clinical Trials Market Overview on Companies, Top Institutes & Clinical Profiles to 2014 5Elbit Imaging Ltd. Announces Investment of US$ 12.5 Million in Insightec by Shanghai GEOC Hengtong Investment Limited Partnership and Fortune China Limited 2Elbit Imaging Ltd. Announces Investment of US$ 12.5 Million in Insightec by Shanghai GEOC Hengtong Investment Limited Partnership and Fortune China Limited 3Pharmaceutical Sector Turning to Health Outcomes Liaisons to Help Industry Navigate Payer-Focused Marketplace 2
(Date:9/14/2014)... 14, 2014 Adults who are planning ... Quotes Pros website to find quotes for life insurance ... year at http://quotespros.com/life-insurance.html is now delivering the ... partners that are preparing the rates information for adults ... most U.S. states. As a way to simplify the ...
(Date:9/14/2014)... York, New York (PRWEB) September 14, 2014 ... ) continue to move forward in courts throughout ... a brief filed in San Francisco Superior Court, ... have asked the judge overseeing the proceeding to ... their cases re-transferred to Los Angeles Superior Court. ...
(Date:9/14/2014)... Top10BestSEOHosting.com always offers truly reliable information ... suppliers carefully, the site has announced that Arvixe ... Best WordPress Hosting suppliers in the current market. ... web hosting provider, and the company’s reputation for ... provider known for its flexible hosting packages, decent ...
(Date:9/14/2014)... 14, 2014 School requires that children read ... that they be screened only for far vision when they ... away. When their eyes do not track effectively or ... will, at best, avoid reading; at worst, they will ... ability to learn. Children who cannot see cannot read. ...
(Date:9/13/2014)... PA (PRWEB) September 13, 2014 “I ... air we breathe, especially in major cities, is quite ... Ancaster, Ontario, Canada. “I thought we deserved a healthier ... they invented THE OXYGENIZER. , THE OXYGENIZER prevents pollutants ... and mouth. In doing so, it provides added peace ...
Breaking Medicine News(10 mins):Health News:Quotes for Life Insurance Now Offered at New Consumer Portal Online 2Health News:DePuy ASR Lawsuit News: Defense Asks Judge Overseeing California Litigation to Deny Opt-Out Plaintiffs’ Re-Transfer Request, Bernstein Liebhard LLP Reports 2Health News:DePuy ASR Lawsuit News: Defense Asks Judge Overseeing California Litigation to Deny Opt-Out Plaintiffs’ Re-Transfer Request, Bernstein Liebhard LLP Reports 3Health News:DePuy ASR Lawsuit News: Defense Asks Judge Overseeing California Litigation to Deny Opt-Out Plaintiffs’ Re-Transfer Request, Bernstein Liebhard LLP Reports 4Health News:Top10BestSEOHosting.com: The Best Linux Web Hosting Suppliers Now Unveiled 2Health News:Personal Air Filtering Device Invented by InventHelp Clients (TOR-9166) 2
... Nov. 11 Ken Herron, Chief Marketing,Executive at ... announced,today that David S. Novak of the Centers ... team at Online Buddies, Inc. as the site,s ... networking site for,gay men, with 2,000,000 members worldwide, ...
... - Global Health,innovator IntraHealth International will participate as ... to improve public health needs in the,West Bank, ... to Washington,DC-based Chemonics International and its subcontractors by ... The new Palestinian Health Sector Reform Project aims ...
... In women, habitual snoring may be an independent ... regardless of sleep apnea occurrences. Researchers from Sweden ... aged 20 to 70 years. The apnea-hypopnea index ... loudly and disturbingly often or very often were ...
... Germany, Nov. 11 Texas Instruments,(NYSE: ... of more than 15 dedicated,embedded processors which ... clinicians while empowering imaging equipment manufacturers to ... smaller and more portable.,These processors target several ...
... his speech today at electronica 2008, Pat O’Doherty, ... spotlighted how sophisticated healthcare semiconductor technology is paving ... and more powerful medical devices for use in ... of devices include those that check glucose levels ...
... 85 Americans die by suicide and hundreds of thousands more ... on suicide have focused on identifying psychiatric risk factors. However, ... published online this month in Social Science and Medicine ... closely analyzing the patterns of suicide in a single geographic ...
Cached Medicine News:Health News:MANHUNT Leads Fight Against Spread of Sexually Transmitted Infections with Launch of MANHUNT Cares; Hires Senior Public Health Strategist from CDC 2Health News:IntraHealth to Support Health Reform in Palestine 2Health News:Journal CHEST: Nov. highlights 2Health News:Video: Medical Imaging Equipment OEMs Can Achieve Faster, More Accurate Results with TI's Portfolio of Embedded Processors and Analog Products 2Health News:Video: Medical Imaging Equipment OEMs Can Achieve Faster, More Accurate Results with TI's Portfolio of Embedded Processors and Analog Products 3Health News:Video: Medical Imaging Equipment OEMs Can Achieve Faster, More Accurate Results with TI's Portfolio of Embedded Processors and Analog Products 4Health News:Video: Medical Imaging Equipment OEMs Can Achieve Faster, More Accurate Results with TI's Portfolio of Embedded Processors and Analog Products 5Health News: Analog Devices Healthcare Director Delivers Speech on Role of Analog Semiconductors in Next-Generation Portable Medical Equipment : ADI's Pat O'Doherty is a featured speaker at electronica 2008. 2Health News: Analog Devices Healthcare Director Delivers Speech on Role of Analog Semiconductors in Next-Generation Portable Medical Equipment : ADI's Pat O'Doherty is a featured speaker at electronica 2008. 3Health News:What happens in Vegas? Place as a risk factor for suicide 2
... Detect™ IgM Capture ELISA is for the ... WNV recombinant antigens (WNRA) in serum as ... of West Nile virus infection in patients ... results must be confirmed by Plaque Reduction ...
Adult; dilates 6.0 to 34.0 French; individually packaged, sterile....
The removable inflation adapter allows the ureteroscope to be removed after the catheter is in place. Supplied sterile in peel-open packages. Intended for one-time use....
The removable inflation/injection adapter allows the cystoscope to be removed after the catheter is in place. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: